spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  sevelamer 

 HSMN NewsFeed - 26 Oct 2021
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2017
Amneal Brings Generic for Renvela(R) to Market and Starts December Strong with Six Product Launches
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 15 Jan 2013
CorMedix Signs Sales and Marketing Agreement with MKM Co-Pharma, Bolsters Commercial Management Team to Ready Neutrolin(R) Catheter Lock Solution for European Market
Biopharmaceuticals Devices Distribution
 HSMN NewsFeed - 4 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to RENVELA(R) and RENAGEL(R)
Biopharmaceuticals Litigation
 HSMN NewsFeed - 7 Oct 2009
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2009
Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Mar 2009
Shire Announces Launch of FOSRENOL(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Mar 2008
Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2007
Fresenius Medical Care Announces: Continued Positive Data from CARE-2 Database
Biopharmaceuticals
 HSMN NewsFeed - 22 Oct 2007
FDA Approves Genzyme's Renvela(TM) for Dialysis Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2007
Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
Biopharmaceuticals
 HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Dec 2006
Genzyme Files for Approval of Sevelamer Carbonate for Patients on Dialysis
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Nov 2006
FOSRENOL(R) Data Show Evidence of Trends Towards Improved Bone Formation in CKD Stage 5 Patients, New Data Presented at ASN Meeting
Biopharmaceuticals
 HSMN NewsFeed - 24 Jul 2006
Genzyme Receives Approval for Additional Manufacturing at Ireland Plant
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jul 2006
Nabi Biopharmaceuticals Releases New Data which Demonstrate Superior Serum Phosphorus Control with PhosLo(R) (calcium acetate) over Sevelamer
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 14

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 14 additional stories matching:
sevelamer
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!